142 related articles for article (PubMed ID: 1968339)
1. Inhibition of pyrimidine metabolism in myeloid leukemia cells by triazole and pyrazole nucleosides.
Matsumoto SS; Fujitaki JM; Nord LD; Willis RC; Lee VM; Sharma BS; Sanghvi YS; Kini GD; Revankar GR; Robins RK
Biochem Pharmacol; 1990 Feb; 39(3):455-62. PubMed ID: 1968339
[TBL] [Abstract][Full Text] [Related]
2. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5'-phosphate dehydrogenase.
Sokoloski JA; Blair OC; Sartorelli AC
Cancer Res; 1986 May; 46(5):2314-9. PubMed ID: 2870796
[TBL] [Abstract][Full Text] [Related]
3. Induction of erythroid differentiation in K562 cells by inhibitors of inosine monophosphate dehydrogenase.
Yu J; Lemas V; Page T; Connor JD; Yu AL
Cancer Res; 1989 Oct; 49(20):5555-60. PubMed ID: 2571408
[TBL] [Abstract][Full Text] [Related]
4. 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2',3'-dideoxyinosine on human immunodeficiency virus in peripheral blood lymphocytes.
Balzarini J; Lee CK; Schols D; De Clercq E
Biochem Biophys Res Commun; 1991 Jul; 178(2):563-9. PubMed ID: 1650194
[TBL] [Abstract][Full Text] [Related]
5. Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
Franchetti P; Cappellacci L; Grifantini M; Barzi A; Nocentini G; Yang H; O'Connor A; Jayaram HN; Carrell C; Goldstein BM
J Med Chem; 1995 Sep; 38(19):3829-37. PubMed ID: 7562914
[TBL] [Abstract][Full Text] [Related]
6. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin.
Franchetti P; Cappellacci L; Sheikha GA; Jayaram HN; Gurudutt VV; Sint T; Schneider BP; Jones WD; Goldstein BM; Perra G; De Montis A; Loi AG; La Colla P; Grifantini M
J Med Chem; 1997 May; 40(11):1731-7. PubMed ID: 9171883
[TBL] [Abstract][Full Text] [Related]
8. Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis.
Balzarini J; Karlsson A; Wang L; Bohman C; Horská K; Votruba I; Fridland A; Van Aerschot A; Herdewijn P; De Clercq E
J Biol Chem; 1993 Nov; 268(33):24591-8. PubMed ID: 7901217
[TBL] [Abstract][Full Text] [Related]
9. An in vivo and in vitro evaluation of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine: an inhibitor of human lymphoblast purine nucleoside phosphorylase.
Willis RC; Robins RK; Seegmiller JE
Mol Pharmacol; 1980 Sep; 18(2):287-95. PubMed ID: 6106888
[No Abstract] [Full Text] [Related]
10. Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K-562 leukemia cells.
Olah E; Natsumeda Y; Ikegami T; Kote Z; Horanyi M; Szelenyi J; Paulik E; Kremmer T; Hollan SR; Sugar J
Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6533-7. PubMed ID: 2901100
[TBL] [Abstract][Full Text] [Related]
11. Virazole (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide; a cytostatic agent.
Müller WE; Maidhof A; Taschner H; Zahn RK
Biochem Pharmacol; 1977 Jun; 26(11):1071-5. PubMed ID: 880258
[No Abstract] [Full Text] [Related]
12. Growth inhibition and induction of cellular differentiation of human myeloid leukemia cells in culture by carbamoyl congeners of ribavirin.
Sanghvi YS; Bhattacharya BK; Kini GD; Matsumoto SS; Larson SB; Jolley WB; Robins RK; Revankar GR
J Med Chem; 1990 Jan; 33(1):336-44. PubMed ID: 2296029
[TBL] [Abstract][Full Text] [Related]
13. IMP dehydrogenase and action of antimetabolites in human cultured blast cells.
Yamada Y; Goto H; Yoshino M; Ogasawara N
Biochim Biophys Acta; 1990 Mar; 1051(3):209-14. PubMed ID: 1968764
[TBL] [Abstract][Full Text] [Related]
14. Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis.
Jayaram HN; Cooney DA; Grusch M; Krupitza G
Curr Med Chem; 1999 Jul; 6(7):561-74. PubMed ID: 10390601
[TBL] [Abstract][Full Text] [Related]
15. Selective guanosine phosphate deficiency in hepatoma cells induced by inhibitors of IMP dehydrogenase.
Kaiser WA; Herrmann B; Keppler DO
Hoppe Seylers Z Physiol Chem; 1980 Oct; 361(10):1503-10. PubMed ID: 6108911
[TBL] [Abstract][Full Text] [Related]
16. Consequences of inhibition of guanine nucleotide synthesis by mycophenolic acid and virazole.
Lowe JK; Brox L; Henderson JF
Cancer Res; 1977 Mar; 37(3):736-43. PubMed ID: 837373
[TBL] [Abstract][Full Text] [Related]
17. Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus.
Ölschläger S; Neyts J; Günther S
Antiviral Res; 2011 Aug; 91(2):89-93. PubMed ID: 21616094
[TBL] [Abstract][Full Text] [Related]
18. Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
Tricot GJ; Jayaram HN; Lapis E; Natsumeda Y; Nichols CR; Kneebone P; Heerema N; Weber G; Hoffman R
Cancer Res; 1989 Jul; 49(13):3696-701. PubMed ID: 2567208
[TBL] [Abstract][Full Text] [Related]
19. Studies on the mechanism of antiviral action of 1-(beta-D-ribofuranosyl)-1,2,4-triazole-3-carboxamide (ribavirin).
Drabikowska AK; Dudycz L; Shugar D
J Med Chem; 1979 Jun; 22(6):653-7. PubMed ID: 222909
[TBL] [Abstract][Full Text] [Related]
20. Assay method for monitoring the inhibitory effects of antimetabolites on the activity of inosinate dehydrogenase in intact human CEM lymphocytes.
Balzarini J; De Clercq E
Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):785-90. PubMed ID: 1359876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]